These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1316045)

  • 1. Fetal death following labetalol administration in pre-eclampsia.
    Olsen KS; Beier-Holgersen R
    Acta Obstet Gynecol Scand; 1992 Feb; 71(2):145-7. PubMed ID: 1316045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic collapse following labetalol administration in preeclampsia.
    Olsen KS; Beier-Holgersen R
    Acta Obstet Gynecol Scand; 1992 Feb; 71(2):151-2. PubMed ID: 1316047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre-eclampsia.
    Jouppila P; Kirkinen P; Koivula A; Ylikorkala O
    Br J Obstet Gynaecol; 1986 Jun; 93(6):543-7. PubMed ID: 3524664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension.
    el-Qarmalawi AM; Morsy AH; al-Fadly A; Obeid A; Hashem M
    Int J Gynaecol Obstet; 1995 May; 49(2):125-30. PubMed ID: 7649315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
    Hjertberg R; Faxelius G; Lagercrantz H
    J Perinat Med; 1993; 21(1):69-75. PubMed ID: 8487154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
    Vermillion ST; Scardo JA; Newman RB; Chauhan SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia.
    Ramanathan J; Sibai BM; Mabie WC; Chauhan D; Ruiz AG
    Am J Obstet Gynecol; 1988 Sep; 159(3):650-4. PubMed ID: 3421264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol therapy in pregnancy induced hypertension: the effects on fetoplacental circulation and fetal outcome.
    Mahmoud TZ; Bjornsson S; Calder AA
    Eur J Obstet Gynecol Reprod Biol; 1993 Jul; 50(2):109-13. PubMed ID: 8405638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.
    Shi DD; Yang FZ; Zhou L; Wang N
    J Clin Pharm Ther; 2016 Dec; 41(6):657-661. PubMed ID: 27578562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of probable labetalol induced hyperkalaemia in pre-eclampsia.
    Thomas B; Abdul Rouf PV; El Kassem W; Al Hail M; Stewart D; Tharannum A; Ahmed A; Al Saadi M
    Int J Clin Pharm; 2014 Dec; 36(6):1130-3. PubMed ID: 25370900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycaemia secondary to labetalol infusion.
    Immanni S; Khan EI; Staunton M
    J Coll Physicians Surg Pak; 2011 May; 21(5):297-8. PubMed ID: 21575539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
    Garden A; Davey DA; Dommisse J
    Clin Exp Hypertens B; 1982; 1(2-3):371-83. PubMed ID: 7139977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perinatal mortality and preeclampsia/eclampsia: influence of HELLP syndrome on the primigravida].
    Van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):323-6. PubMed ID: 7622782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe adverse effects of maternal labetalol in a premature infant.
    Haraldsson A; Geven W
    Acta Paediatr Scand; 1989 Nov; 78(6):956-8. PubMed ID: 2603724
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
    Kausar M; Husain S; Hussain R
    Afr Health Sci; 2023 Mar; 23(1):320-325. PubMed ID: 37545898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood rheology in pre-eclampsia and intrauterine growth retardation: effects of blood pressure reduction with labetalol.
    Lang GD; Lowe GD; Walker JJ; Forbes CD; Prentice CR; Calder AA
    Br J Obstet Gynaecol; 1984 May; 91(5):438-43. PubMed ID: 6722062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
    Heida KY; Zeeman GG; Van Veen TR; Hulzebos CV
    Early Hum Dev; 2012 Jul; 88(7):503-7. PubMed ID: 22525036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic hepatocellular hepatitis due to labetalol].
    Castiella A; Iglesias U; Zapata E; Zubiaurre L; Iribarren A
    Gastroenterol Hepatol; 2015 May; 38(5):326-7. PubMed ID: 25073680
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants.
    Hjertberg R; Faxelius G; Belfrage P
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):611-5. PubMed ID: 8259746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.